Scientific Program

CONFIRMED TOPICS AND SPEAKERS

• Optimizing Stem Cell-Derived Islets for Replacement Therapy | Juan Alvarez-Dominguez, USA
• T1D in Middle and Low-Income Countries: Clinician perspectives | Carlos Antillon, Mexico
• Implementing the Next-Generation T1D Care Model: A Field in Crisis, Addressing the Shortage of Practicing Endocrinologists | Tandy Aye, USA
• Enhancing T1D Care with AI | Tadej Battelino, Slovenia
• Involving PWT1D and HCPs in Early Detection | Manuela Battaglia, Italy
• Cost-Effectiveness of Screening: The Australian Perspective | Kirstine Bell, Australia
• Do Adjunctive Therapies Improve AID Outcomes? | Natalie Bellini, USA
• T1D in Middle and Low-Income Countries: Advocacy and Policy Perspective | David Beran, Switzerland
• Intrusive Hypoglycemia and How to Reduce It | Pratik Choudhary, UK
• SGLT Inhibitor Therapies for Glucometabolic Control in T1D | Anders Carlson, USA
• Optimizing Stem Cell-Derived Islets for Replacement Therapy | Per-Ola Carlsson, Sweden
• Optimizing Stem Cell-Derived Islets for Replacement Therapy | Hongkui Deng, China
• Risks and Benefits of Off-Label Use to Protect Kidneys | Ian de Boer, USA
• Update and Best Practices for T1D in Primary Care | Osagie Ebekozien, USA
• Clinical Implementation of AI in Benchmarking | Juan Espinosa, USA
• Advancing Our Mission Through Breakthrough T1D Centers of Excellence | David Harlan, USA
• Update and Best Practices from the SWEET Registry | Olga Kordonouri, Germany
• The Digital Twin in Type 1 Diabetes Technology | Boris Kovatchev, USA
• The Next-Generation Disease-Modifying Therapies: GAD65 Vaccine | Johnny Ludvigsson, Sweden
• Activity, Exercise, and Sports Without Lows: Advances in AID | Othmar Moser, Austria
• Perspectives on Key Issues from HCPs Living with T1D: Young Adults and Technology Adoption, T1D and Pregnancy | Kathryn Nagel, USA
• Old and New Challenges in Type 1 Diabetes: How Can HCPs Communicate with Children and Adults in Early-Stage T1D? | Ellen O’Donnell, USA
• How Do We Reduce the Risk for DKA? From Current Practice to Emerging Technologies | David O’Neal, Australia
• The Role of the Diabetology Pharmacist in Improving Cardiovascular, Kidney, and Metabolic Health | Katelyn O’Brien, USA
• Role of GRS in Risk Assessment | Richard Oram, UK
• Optimizing Stem Cell-Derived Islets for Replacement Therapy | Audrey Parent, USA
• How Can Stem Cell-Derived Islets Be Offered to More People with T1D? Initial Results from the Delphi Study | Lorenzo Piemonti, Italy
• Immunology and Immunosuppression in Islet Transplantation | Sabarinathan Ramachandran, USA
• Update and Best Practices from the T1DX-QI | Nicole Rioles, USA
• Toward Centers of Reference | James Shaw, UK
• Disease-Modifying Therapies in the Wild: Ask the Experts, Supporting Early-Stage T1D in Diverse Clinical Settings | Kimber Simmons, USA
• Beyond Glucose Control: Addressing Insulin Resistance and Other Metabolic Challenges in T1D | Janet Snell-Bergeon, USA
• Old and New Challenges in Type 1 Diabetes: Stigma Is Not a Welcome Guest in the T1D Clinic | Jane Speight, Australia
• CGM in Early Stages | Andrea Steck, USA
• Perspectives on Key Issues from HCPs Living with T1D: Perspective on Clinical Trial Participation | Ram Subramanyan, USA
• Algorithmic Anxiety: Trust and Frustration with CGM and AID Systems | Molly Tanenbaum, USA
• Advancing Our Mission Through Breakthrough T1D Centers of Excellence | Bruce Verchere, Canada
• Perspectives on Key Issues from HCPs Living with T1D: Stigmatizing Language | Sarah Westen, USA
• Perspectives on Key Issues from HCPs Living with T1D: Diabetes Technology Supply Distress, the Underappreciated Modern Challenge for People with T1D | Andrew Welch, USA
• Optimizing Stem Cell-Derived Islets for Replacement Therapy | Piotr Witowski, USA